NovoSeven® RT Coagulation Factor VIIa (Recombinant).
NovoSeven® RT is used to treat bleeding episodes in people with hemophilia A or B with inhibitors, congenital Factor VII deficiency, Glanzmann’s thrombasthenia with resistance to platelets, and acquired hemophilia.
 
Hello, [First name].
[I’m really inspired by your experience with a rare bleeding disorder, and I think it could help others in the community.
We’re working on an exciting new campaign called “Be the Face.” I think you would be a great candidate to share your story. By sharing, you may be able to help others realize they are more than just their bleeding disorder.]
[I’m reaching out to let you know how inspired I am by your experience with a rare bleeding disorder. I feel others in the community could learn a lot from you!
Your story would be an awesome fit for our “Be the Face” campaign. By sharing it, I think you will really help people feel less alone.]
[I hope you’re doing great. I always thought you had a powerful story to tell about life with a rare bleeding disorder, and I really think others could benefit from hearing your experience.
I’d love for you to submit your story to our “Be the Face” campaign because I know it would help others feel less alone. By sharing your story, you will be reminding others that they are more than their bleeding disorder.]
I hope you’ll consider sharing your story with the rest of the bleeding disorders community. Head to www.betheface.com for more information about “Be the Face” and how to get started.
Please feel free to contact me to learn more about the campaign or if you have any questions about NovoSeven® RT!
[Rep Name]
[Email Address]
[Phone number]
Selected Important Safety Information
What is the most important information I should know about NovoSeven® RT?
NovoSeven® RT may cause serious side effects, including:
  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/ or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT
What is NovoSeven® RT?
NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for:
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia
Important Safety Information (cont’d)
  • You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness
What should I tell my healthcare provider before using NovoSeven® RT?
  • Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots:
  congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates)
  are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding
  history of heart or blood vessel diseases
 
  • Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies
What are the possible side effects of NovoSeven® RT?
  • The most common and serious side effects are blood clots
  • Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction
Please click here for Prescribing Information.
NovoSeven® RT is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
NovoSeven® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2021 Novo Nordisk  All rights reserved.  US21NSVN00008  February 2021
Novo Nordisk logo.
Subject Options (copy and paste one to subject line; delete the rest):
Your story may help others with a bleeding disorder feel less alone
I think your inspiring experience will help the bleeding disorders community
Your story is powerful, and I know it will inspire others.
It was so great to talk to you and hear your story
Here’s more info about the “Be the Face” campaign I mentioned
Following up from our introduction with an exciting opportunity!
I’ve always thought you had a powerful story that should be shared
Your story is perfect for the “Be the Face” campaign I mentioned
Sharing your experience could really inspire others